Findings Could Lead to Treatments for Charcot-Marie-Tooth Disease
22 October, 2015
Scientists have found what could one day lead to a promising treatment for those with a crippling disease, Duchenne muscular dystrophy.
15 October, 2015
The Centre for Process Innovation (CPI) has officially launched the new £38m National Biologics Manufacturing Centre in Darlington, Co. Durham. The new Centre was opened by Jo Johnson, Minister of State for Universities and Science and Steve Bagshaw, CEO of Fujifilm Diosynth Biotechnologies. The new Centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.
14 October, 2015
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies
13 October, 2015
CANCER RESEARCH UK has today (Monday) launched Grand Challenges* - the biggest and most ambitious cancer grants in the world - which aim to overcome the greatest barriers standing in the way of beating cancer.
12 October, 2015
Scientists associated with A1M Pharma have published a scientific article that deepens the understanding of how free hemoglobin affects the function of the heart and the possibility to neutralize these effects with A1M, a protein that occurs naturally in the human body. The article was published on September 25 in the scientific journal Free Radical Biology and Medicine.
11 October, 2015
Three decades ago two emerging neuroscientists, Barbara Sahakian and Trevor Robbins from University of Cambridge received a grant from The Wellcome Trust to fund their development of the Cambridge Neuropsychological Automated Test Battery or CANTAB™. Delegates to CANTAB 30, a special conference held recently at the University of Cambridge to mark 30 years of expert cognitive neuroscience, heard how CANTAB™, has fundamentally changed the way brain function is measured and understood, leading to the dawn of a new era in neuroscience.
10 October, 2015
Cambridge Cognition Holdings plc (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces two new licence agreements which extend the Company’s testing capabilities into new areas of research, enabling assessment of 'Hot' cognition – mental processes that are influenced by emotion and social interaction – to be performed reliably and routinely for the first time.
09 October, 2015
overuse“The rise of resistance to antibiotics (Anti-Microbial Resistance, AMR) is largely a consequence of human action, and is as much a societal problem as a technological one.”
08 October, 2015
According to patent filing research conducted by intellectual property firm Withers & Rogers, the 3D printing of medical devices and prosthetics is set to become common practice over the next 10 years. Due to the commercial limitations however, we’re unlikely to see 3D-printed drugs manufactured on such a wide basis.
07 October, 2015